suzhou Latest News (Jiangsu, China)

RicoCNC mainly offers a range of spare parts for SCM woodworking machinery with good price. We also hope where there is SCM, there is a Rico CNC in the future.

Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell therapies targeting osteoarthritis, spinal cord injury and various cancers was recently presented a 2020 "China's Most Promising Company" award.

When it comes to chocolate taste and flavor people from most of parts of civilized world has tasted it at least once or twice every year. There are seasons and festivals when people engage in making chocolates and related flavored dishes.

Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell therapies targeting osteoarthritis, spinal cord injury and various cancers recently funded in part a study titled "Solid-phase inclusion as a...

DumboFab Studio, a professional multimedia software developer, releases its video converter software to help users convert, resize and edit large/4K videos easily at a super fast speed.

EaseFab Studio announces official online deals in the summer shopping season. Customers will enjoy the biggest discount this year and free giveaway on all hot products of EaseFab studio.

Keeping spare parts on hand for your woodworking machines can save you a lot of machine downtime and a lot of headaches.

Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, recently provided the...

Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, today announced that it..

Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell-based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, today announced that...